• 1
    Carvounis PE, Herman DC, Cha S, Burke JP. Incidence and outcomes of uveitis in juvenile rheumatoid arthritis: a synthesis of the literature. Graefes Arch Clin Exp Ophthalmol 2006; 244: 28190.
  • 2
    Manners PJ, Bower C. Worldwide prevalence of juvenile arthritis: why does it vary so much? J Rheumatol 2002; 29: 152030.
  • 3
    Berntson L, Andersson Gare B, Fasth A, Herlin T, Kristinsson J, Lahdenne P, et al, for the Nordic Study Group. Incidence of juvenile idiopathic arthritis in the Nordic countries: a population based study with special reference to the validity of the ILAR and EULAR criteria. J Rheumatol 2003; 30: 227582.
  • 4
    Paivonsalo-Hietanen T, Tuominen J, Saari KM. Uveitis in children: population-based study in Finland. Acta Ophthalmol Scand 2000; 78: 848.
  • 5
    Heiligenhaus A, Niewerth M, Ganser G, Heinz C, Minden K. Prevalence and complications of uveitis in juvenile idiopathic arthritis in a population-based nation-wide study in Germany: suggested modification of the current screening guidelines. Rheumatology (Oxford) 2007; 46: 10159.
  • 6
    Dana MR, Merayo-Lloves J, Schaumberg DA, Foster CS. Visual outcomes prognosticators in juvenile rheumatoid arthritis-associated uveitis. Ophthalmology 1997; 104: 23644.
  • 7
    De Boer J, Wulffraat N, Rothova A. Visual loss in uveitis of childhood. Br J Ophthalmol 2003; 87: 87984.
  • 8
    Edelsten C, Reddy MA, Stanford MR, Graham EM. Visual loss associated with paediatric uveitis in English primary and referral centers. Am J Ophthalmol 2003; 135: 67680.
  • 9
    Kotaniemi K, Aho K, Kotaniemi A. Uveitis as a cause of visual loss in arthritides and comparable conditions. J Rheumatol 2001; 28: 30912.
  • 10
    Mingels A, Hudde T, Heinz C, Heiligenhaus A. Vision threatening complications in uveitis in childhood. Ophthalmologe 2005; 105: 47784. In German.
  • 11
    Wolf MD, Lichter PR, Ragsdale CG. Prognostic factors in the uveitis of juvenile rheumatoid arthritis. Ophthalmology 1987; 94: 12428.
  • 12
    Kotaniemi K, Savolainen A, Karma A, Aho K. Recent advances in uveitis of juvenile idiopathic arthritis. Surv Ophthalmol 2003; 48: 489502.
  • 13
    Smith JA, Thompson DJ, Whitcup SM, Suhler E, Clarke G, Smith S, et al. A randomized, placebo-controlled, double-masked clinical trial of etanercept for the treatment of uveitis associated with juvenile idiopathic arthritis. Arthritis Rheum 2005; 53: 1823.
  • 14
    Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of uveitis nomenclature for reporting clinical data: results of the first international workshop. Am J Ophthalmol 2005; 140: 50916.
  • 15
    Tugwell P, Boers M, Brooks P, Simon L, Strand V, Idzerda L. OMERACT: an international initiative to improve outcome measurement in rheumatology. Trials 2007; 8: 3843.
  • 16
    Delbecq AL, Van de Ven AH, Gustafson DH. Group techniques for program planning: a guide to nominal group and Delphi processes. Glenview (IL): Scott Foresman and Company; 1975.
  • 17
    Kempen JH, Ganesh SK, Sangwan VS, Rathinam SR. Interobserver agreement in grading activity and site of inflammation in eyes of patients with uveitis. Am J Ophthalmol 2008; 146: 8138.
  • 18
    Holland GN. A reconsideration of anterior chamber flare and its clinical relevance for children with chronic anterior uveitis: an American Ophthalmological Society thesis. Trans Am Ophthalmol Soc 2007; 105: 34464.
  • 19
    Thorne JE, Woreta F, Kedhar SR, Dunn JP, Jabs DA. Juvenile idiopathic arthritis-associated uveitis: incidence of ocular complications and visual acuity loss. Am J Ophthalmol 2007; 143: 8406.
  • 20
    Ladas JG, Wheeler NC, Morhun PJ, Rimmer SO, Holland GN. Laser flare-cell photometry: methodology and clinical applications. Surv Ophthalmol 2006; 50: 2747.
  • 21
    Vision in Preschoolers Study Group. Comparison of preschool vision screening tests as administered by licensed eye care professionals in the Vision in Preschoolers Study. Ophthalmology 2004; 111: 63750.
  • 22
    Edelsten C, Lee V, Bentley CR, Kanski JJ, Graham EM. An evaluation of baseline risk factors predicting severity in juvenile idiopathic arthritis associated uveitis and other chronic anterior uveitis in early childhood. Br J Ophthalmol 2002; 86: 516.
  • 23
    Chylack LT Jr, Wolfe JK, Singer DM, Leske MC, Bullimore MA, Bailey IL, et al. The lens classification system III: the longitudinal study of cataract study group. Arch Ophthalmol 1993; 111: 8316.
  • 24
    Woreta F, Thorne JE, Jabs DA, Kedhar SR, Dunn JP. Risk factors for ocular complications and poor visual acuity at presentation among patients with uveitis associated with juvenile idiopathic arthritis. Am J Ophthalmol 2007; 143: 64755.
  • 25
    Kump LI, Cervantes-Castaneda RA, Androudi SN, Foster CS. Analysis of pediatric uveitis cases at a tertiary referral center. Ophthalmology 2005; 112: 128792.
  • 26
    Ducos de Lahitte G, Terrada C, Tran TH, Cassoux N, LeHoang P, Kodjikian L, et al. Maculopathy in uveitis of juvenile idiopathic arthritis: an optical coherence tomography study. Br J Ophthalmol 2008; 92: 649.
  • 27
    Sijssens KM, Rothova A, Berendschot TT, de Boer JH. Ocular hypertension and secondary glaucoma in children with uveitis. Ophthalmology 2006; 113: 8539.
  • 28
    Ruperto N, Ravelli A, Pistorio A, Malattia C, Cavuto S, Gado-West L, et al, for the Paediatric Rheumatology International Trials Organisation (PRINTO). Cross-cultural adaptation and psychometric evaluation of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ) in 32 countries: review of the general methodology. Clin Exp Rheumatol 2001; 19 Suppl 23: 19.
  • 29
    Varni JM, Seid M, Kurtin PS. PedsQL 4.0: reliability and validity of the pediatric quality of life inventory version 4.0 generic core scales in healthy and patient populations. Med Care 2001; 39: 80012.
  • 30
    Sijssens KM, Rothova A, Van De Vijver DA, Stilma JS, De Boer JH. Risk factors for the development of cataract requiring surgery in uveitis associated with juvenile idiopathic arthritis. Am J Ophthalmol 2007; 144: 5749.
  • 31
    Williamson P, Gamble C. Identification and impact of outcome selection bias in meta-analysis. Stat Med 2005; 24: 154761.
  • 32
    Sinha IP, Smyth RL, Williamson PR. Using the Delphi technique to determine which outcomes to measure in clinical trials: recommendations for future based on a systemic review of existing studies. PLoS Med 2011; 8: e1000393.
  • 33
    Sinha I, Jones L, Smyth RL, Williamson PR. A systemic review of studies that aim to determine which outcomes to measure in clinical trials in children. PLoS Med 2008; 5: e96.
  • 34
    Felius J, Stager DR Sr, Berry PM, Fawcett SL, Stager DR Jr, Salomao SR, et al. Development of an instrument to assess vision-related quality of life in young children. Am J Ophthalmol 2004; 138: 36272.
  • 35
    Angeles-Han ST, Griffin KW, Harrison MJ, Lehman TJ, Leong T, Robb RR, et al. Development of a vision-related quality of life instrument for children ages 8–18 years for use in juvenile idiopathic arthritis–associated uveitis. Arthritis Care Res (Hoboken) 2011; 63: 125461.
  • 36
    Ruperto N, Ravelli A, Cuttica R, Espada G, Ozen S, Porras O, et al, for the Pediatric Rheumatology International Trials Organization (PRINTO) and the Pediatric Rheumatology Collaborative Study Group (PRCSG). The Pediatric Rheumatology International Trials Organization criteria for the evaluation of response to therapy in juvenile systemic lupus erythematosus: prospective validation of the disease activity core set. Arthritis Rheum 2005; 52: 285464.